|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| License fee revenue and other revenue | |||||
| Milestone revenue | |||||
| Royalty revenue | |||||
| Total revenue | |||||
| Cost of revenues | |||||
| Operating expenses | |||||
| General and administrative | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| License fee expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Sale of royalty and milestone rights, net of transaction costs (Note 13) | |||||
| Other income (expense) | |||||
| Net loss | |||||
| Net loss to common stockholders | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive loss | |||||
| Loss per common share - basic (in usd per share) | |||||
| Loss per common share - diluted (in usd per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...